Published in
Elsevier, Antiviral Research, (170), p. 104588, 2019
DOI: 10.1016/j.antiviral.2019.104588
Links
Tools
FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis
Journal article published in 2019 by
Changbo Qu,
Yang Li,
Yunlong Li,
Peifa Yu,
Pengfei Li,
Joanne M. Donkers 
,
Stan F. J. van de Graaf,
Robert A. de Man,
Maikel P. Peppelenbosch,
Qiuwei Pan
,
Stan F. J. van de Graaf,
Robert A. de Man,
Maikel P. Peppelenbosch,
Qiuwei Pan
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 